M. C. Chambela

Correlation of transforming growth factor-β1 and tumour necrosis factor levels with left ventricular function in Chagas disease

Eduardo O. V. Curvo, R. Saraiva, M. Waghabi, 2018, Memorias do Instituto Oswaldo Cruz.

Matrix Metalloproteinases 2 and 9 Are Differentially Expressed in Patients with Indeterminate and Cardiac Clinical Forms of Chagas Disease

A. Teixeira-Carvalho, R. Corrêa-Oliveira, R. Saraiva, 2013, Infection and Immunity.

Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis.

B. Wanke, R. Oliveira, G. M. S. Silva, 2014, Medical mycology.

Safety of benznidazole use in the treatment of chronic Chagas' disease.

G. M. Sperandio da Silva, A. Hasslocher-Moreno, S. Xavier, 2012, The Journal of antimicrobial chemotherapy.

Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial

A. Sousa, R. Saraiva, M. Mediano, 2020, British journal of clinical pharmacology.

TGF-β Polymorphisms Are a Risk Factor for Chagas Disease

R. Saraiva, P. Cabello, S. Bailly, 2018, Disease markers.

Impact of pharmaceutical care on the quality of life of patients with Chagas disease and heart failure: randomized clinical trial

A. Hasslocher-Moreno, A. Sousa, R. Saraiva, 2012, Trials.

Correlation of 6‐min walk test with left ventricular function and quality of life in heart failure due to Chagas disease

R. Saraiva, M. Mediano, A. Japiassú, 2017, Tropical medicine & international health : TM & IH.

Left atrial and left ventricular diastolic function in chronic Chagas disease.

A. Hasslocher-Moreno, A. Sousa, R. Saraiva, 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.